Biorem Inc (TSE:BRM)
:BRM
BRM Stock Chart & Stats
C$2.65
-C$0.02(-0.63%)
At close: 4:00 PM EST
C$2.65
-C$0.02(-0.63%)
Day’s Range― - ―
52-Week RangeC$1.67 - C$2.82
Previous CloseN/A
Volume29.81K
Average Volume (3M)32.44K
Market Cap
C$39.33M
Enterprise ValueC$33.85M
Total Cash (Recent Filing)C$8.35M
Total Debt (Recent Filing)C$3.08M
Price to Earnings (P/E)6.8
Beta0.39
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,117,027
10 Day Avg. Volume30,537
30 Day Avg. Volume32,440
Financial Highlights & Ratios
PEG Ratio0.44
Price to Book (P/B)4.53
Price to Sales (P/S)1.28
P/FCF Ratio14.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$45.20M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Stronger Balance SheetSustained low leverage and rising equity provide resilience for a project-driven industrial business. This reduces refinancing risk, supports bidding on larger engineered projects, and offers capacity to absorb revenue volatility or fund targeted investments over the next several quarters.
High Return On EquityA near-20% ROE indicates efficient use of capital in its core engineering and services business. Persistently strong ROE supports reinvestment, funds aftermarket expansion, and signals competitive margins versus many industrial peers over a multi-quarter horizon.
Aftermarket & Services Revenue StreamRecurring aftermarket and service income tied to installed systems creates a steadier, higher-margin revenue layer beyond one-off project sales. Over months this stabilizes cash flows, improves lifetime customer value, and supports cross-selling that strengthens long-term customer relationships.
Bears Say
TTM Revenue Decline And Margin ErosionFalling revenue and compressed margins point to either weaker project demand or rising input/project costs. If persistent, this reduces free cash generation and return metrics, pressuring capital allocation and limiting the company's ability to scale or invest in new product/service initiatives over coming quarters.
Free Cash Flow Decline & VolatilitySignificant FCF decline and historical volatility undermine the company's ability to self-fund project working capital spikes and aftermarket investments. Persistent variability raises the probability of external financing needs or delayed capex, which can impair execution on multi-quarter timelines.
Project-based Model Drives Revenue VolatilityAn engineered-to-order project mix naturally creates lumpy revenue and backlog sensitivity. Coupled with recent negative revenue growth, this structural cadence risk can lead to inconsistent quarterly results, making multi-quarter planning and steady margin expansion more challenging without larger recurring revenue gains.
Biorem Inc News
BRM FAQ
What was Biorem Inc’s price range in the past 12 months?
Biorem Inc lowest stock price was C$1.67 and its highest was C$2.82 in the past 12 months.
What is Biorem Inc’s market cap?
Biorem Inc’s market cap is C$39.33M.
When is Biorem Inc’s upcoming earnings report date?
Biorem Inc’s upcoming earnings report date is May 14, 2026 which is in 38 days.
How were Biorem Inc’s earnings last quarter?
Currently, no data Available
Is Biorem Inc overvalued?
According to Wall Street analysts Biorem Inc’s price is currently Overvalued.
Does Biorem Inc pay dividends?
Biorem Inc does not currently pay dividends.
What is Biorem Inc’s EPS estimate?
Biorem Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biorem Inc have?
Biorem Inc has 16,117,027 shares outstanding.
What happened to Biorem Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biorem Inc?
Currently, no hedge funds are holding shares in TSE:BRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biorem Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.30%
12-Months-Change
Fundamentals
Return on Equity
18.99%
Trailing 12-Months
Asset Growth
13.96%
Trailing 12-Months
Company Description
Biorem Inc
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
Technical Analysis
Dundee Sustainable Technologies
―
Sharc International Systems Inc
―
Questor Technology
―
Thermal Energy International
―
Greenlane Renewables Inc
―
Options Prices
Currently, No data available
---